These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25670333)

  • 1. Apolipoprotein E ε4 genotype and the temporal relationship between depression and dementia.
    Karlsson IK; Bennet AM; Ploner A; Andersson TM; Reynolds CA; Gatz M; Pedersen NL
    Neurobiol Aging; 2015 Apr; 36(4):1751-1756. PubMed ID: 25670333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of Apolipoprotein E Genotypes, Lifestyle Factors and Future Risk of Dementia-Related Mortality: The Cohort of Norway (CONOR).
    Strand BH; Rosness TA; Engedal K; Magnus P; Bergem AL; Schirmer H; Bjertness E; Knudsen GP
    Dement Geriatr Cogn Disord; 2015; 40(3-4):137-47. PubMed ID: 26088392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E genotype and cerebrovascular alterations can influence conversion to dementia in patients with mild cognitive impairment.
    Viticchi G; Falsetti L; Vernieri F; Altamura C; Altavilla R; Luzzi S; Bartolini M; Provinciali L; Silvestrini M
    J Alzheimers Dis; 2014; 41(2):401-10. PubMed ID: 24625799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How can elderly apolipoprotein E ε4 carriers remain free from dementia?
    Ferrari C; Xu WL; Wang HX; Winblad B; Sorbi S; Qiu C; Fratiglioni L
    Neurobiol Aging; 2013 Jan; 34(1):13-21. PubMed ID: 22503000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis.
    Ossenkoppele R; Jansen WJ; Rabinovici GD; Knol DL; van der Flier WM; van Berckel BN; Scheltens P; Visser PJ; ; Verfaillie SC; Zwan MD; Adriaanse SM; Lammertsma AA; Barkhof F; Jagust WJ; Miller BL; Rosen HJ; Landau SM; Villemagne VL; Rowe CC; Lee DY; Na DL; Seo SW; Sarazin M; Roe CM; Sabri O; Barthel H; Koglin N; Hodges J; Leyton CE; Vandenberghe R; van Laere K; Drzezga A; Forster S; Grimmer T; Sánchez-Juan P; Carril JM; Mok V; Camus V; Klunk WE; Cohen AD; Meyer PT; Hellwig S; Newberg A; Frederiksen KS; Fleisher AS; Mintun MA; Wolk DA; Nordberg A; Rinne JO; Chételat G; Lleo A; Blesa R; Fortea J; Madsen K; Rodrigue KM; Brooks DJ
    JAMA; 2015 May; 313(19):1939-49. PubMed ID: 25988463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E epsilon 4 genotype and a physically active lifestyle in late life: analysis of gene-environment interaction for the risk of dementia and Alzheimer's disease dementia.
    Luck T; Riedel-Heller SG; Luppa M; Wiese B; Köhler M; Jessen F; Bickel H; Weyerer S; Pentzek M; König HH; Prokein J; Ernst A; Wagner M; Mösch E; Werle J; Fuchs A; Brettschneider C; Scherer M; Maier W
    Psychol Med; 2014 Apr; 44(6):1319-29. PubMed ID: 23883793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Education halves the risk of dementia due to apolipoprotein ε4 allele: a collaborative study from the Swedish brain power initiative.
    Wang HX; Gustafson DR; Kivipelto M; Pedersen NL; Skoog I; Windblad B; Fratiglioni L
    Neurobiol Aging; 2012 May; 33(5):1007.e1-7. PubMed ID: 22056199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E epsilon4 allele genotype and the effect of depressive symptoms on the risk of dementia in men: the Honolulu-Asia Aging Study.
    Irie F; Masaki KH; Petrovitch H; Abbott RD; Ross GW; Taaffe DR; Launer LJ; White LR
    Arch Gen Psychiatry; 2008 Aug; 65(8):906-12. PubMed ID: 18678795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 9-year prospective population-based study on the association between the APOE*E4 allele and late-life depression in Sweden.
    Skoog I; Waern M; Duberstein P; Blennow K; Zetterberg H; Börjesson-Hanson A; Östling S; Guo X; Kern J; Gustafson D; Gudmundsson P; Marlow T; Kern S
    Biol Psychiatry; 2015 Nov; 78(10):730-6. PubMed ID: 25708227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The APOE epsilon 4 polymorphism does not predict late onset depression: the Three-City Study.
    Tully PJ; Péres K; Berr C; Tzourio C
    Neurobiol Aging; 2016 Apr; 40():191.e9-191.e10. PubMed ID: 26785975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study.
    Huang W; Qiu C; von Strauss E; Winblad B; Fratiglioni L
    Arch Neurol; 2004 Dec; 61(12):1930-4. PubMed ID: 15596614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E epsilon4 and age at onset of sporadic and familial Alzheimer disease in Caribbean Hispanics.
    Olarte L; Schupf N; Lee JH; Tang MX; Santana V; Williamson J; Maramreddy P; Tycko B; Mayeux R
    Arch Neurol; 2006 Nov; 63(11):1586-90. PubMed ID: 17101827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.
    Hsiung GY; Sadovnick AD; Feldman H
    CMAJ; 2004 Oct; 171(8):863-7. PubMed ID: 15477624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of MAPT H1 and APOE ε4 on transition from mild cognitive impairment to dementia.
    Samaranch L; Cervantes S; Barabash A; Alonso A; Cabranes JA; Lamet I; Ancín I; Lorenzo E; Martínez-Lage P; Marcos A; Clarimón J; Alcolea D; Lleó A; Blesa R; Gómez-Isla T; Pastor P
    J Alzheimers Dis; 2010; 22(4):1065-71. PubMed ID: 20930301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical activity modifies the influence of apolipoprotein E ε4 allele and type 2 diabetes on dementia and cognitive impairment among older Mexican Americans.
    Shih IF; Paul K; Haan M; Yu Y; Ritz B
    Alzheimers Dement; 2018 Jan; 14(1):1-9. PubMed ID: 28692819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E epsilon4 magnifies lifestyle risks for dementia: a population-based study.
    Kivipelto M; Rovio S; Ngandu T; Kåreholt I; Eskelinen M; Winblad B; Hachinski V; Cedazo-Minguez A; Soininen H; Tuomilehto J; Nissinen A
    J Cell Mol Med; 2008 Dec; 12(6B):2762-71. PubMed ID: 18318693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased risk of dementia following mild head injury for carriers but not for non-carriers of the APOE epsilon4 allele.
    Sundström A; Nilsson LG; Cruts M; Adolfsson R; Van Broeckhoven C; Nyberg L
    Int Psychogeriatr; 2007 Feb; 19(1):159-65. PubMed ID: 16684399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refined carbohydrate-rich diet is associated with long-term risk of dementia and Alzheimer's disease in apolipoprotein E ε4 allele carriers.
    Gentreau M; Chuy V; Féart C; Samieri C; Ritchie K; Raymond M; Berticat C; Artero S
    Alzheimers Dement; 2020 Jul; 16(7):1043-1053. PubMed ID: 32506713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.